Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG - PubMed (original) (raw)
Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG
S L Gorbach et al. Lancet. 1987.
No abstract available
Similar articles
- [Fecal bacteriotherapy for the treatment of recurrent Clostridium difficile colitis used in the Clinic of Infectious Diseases of the University Hospital Brno in 2010-2014 - a prospective study].
Polák P, Freibergerová M, Husa P, Juránková J, Svačinka R, Mikešová L, Kocourková H, Mihalčin M, Skalická R, Stebel R, Porubčanová M. Polák P, et al. Epidemiol Mikrobiol Imunol. 2015 Oct;64(4):232-5. Epidemiol Mikrobiol Imunol. 2015. PMID: 26795227 Czech. - Surgical aspects of fulminant Clostridium difficile colitis.
Butala P, Divino CM. Butala P, et al. Am J Surg. 2010 Jul;200(1):131-5. doi: 10.1016/j.amjsurg.2009.07.040. Epub 2010 Apr 21. Am J Surg. 2010. PMID: 20409527 Review. - Fecal microbiota transplantation for Clostridium difficile-associated colitis in a severely immunocompromized critically ill AIDS patient: a case report.
Schünemann M, Oette M. Schünemann M, et al. AIDS. 2014 Mar 13;28(5):798-9. doi: 10.1097/QAD.0000000000000148. AIDS. 2014. PMID: 24983544 No abstract available. - Bacteriotherapy for clostridium difficile colitis.
Wilson KH. Wilson KH. Lancet. 1989 Nov 4;2(8671):1096. doi: 10.1016/s0140-6736(89)91103-3. Lancet. 1989. PMID: 2572812 No abstract available. - Coexisting cytomegalovirus infection in immunocompetent patients with Clostridium difficile colitis.
Chan KS, Lee WY, Yu WL. Chan KS, et al. J Microbiol Immunol Infect. 2016 Dec;49(6):829-836. doi: 10.1016/j.jmii.2015.12.007. Epub 2016 Jan 12. J Microbiol Immunol Infect. 2016. PMID: 26850320 Review.
Cited by
- Clinically proven natural products, vitamins and mineral in boosting up immunity: A comprehensive review.
Al Mahmud A, Shafayet Ahmed Siddiqui, Karim MR, Al-Mamun MR, Akhter S, Sohel M, Hasan M, Bellah SF, Amin MN. Al Mahmud A, et al. Heliyon. 2023 Apr;9(4):e15292. doi: 10.1016/j.heliyon.2023.e15292. Epub 2023 Apr 7. Heliyon. 2023. PMID: 37089292 Free PMC article. Review. - Bioengineered Probiotics: Synthetic Biology Can Provide Live Cell Therapeutics for the Treatment of Foodborne Diseases.
Cruz KCP, Enekegho LO, Stuart DT. Cruz KCP, et al. Front Bioeng Biotechnol. 2022 May 17;10:890479. doi: 10.3389/fbioe.2022.890479. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35656199 Free PMC article. Review. - Probiotics: insights and new opportunities for Clostridioides difficile intervention.
Pal R, Athamneh AIM, Deshpande R, Ramirez JAR, Adu KT, Muthuirulan P, Pawar S, Biazzo M, Apidianakis Y, Sundekilde UK, de la Fuente-Nunez C, Martens MG, Tegos GP, Seleem MN. Pal R, et al. Crit Rev Microbiol. 2023 May;49(3):414-434. doi: 10.1080/1040841X.2022.2072705. Epub 2022 May 15. Crit Rev Microbiol. 2023. PMID: 35574602 Free PMC article. Review. - Probiotics: Should All Patients Take Them?
Katkowska M, Garbacz K, Kusiak A. Katkowska M, et al. Microorganisms. 2021 Dec 18;9(12):2620. doi: 10.3390/microorganisms9122620. Microorganisms. 2021. PMID: 34946221 Free PMC article. Review. - Frontiers in antibiotic alternatives for Clostridioides difficile infection.
Phanchana M, Harnvoravongchai P, Wongkuna S, Phetruen T, Phothichaisri W, Panturat S, Pipatthana M, Charoensutthivarakul S, Chankhamhaengdecha S, Janvilisri T. Phanchana M, et al. World J Gastroenterol. 2021 Nov 14;27(42):7210-7232. doi: 10.3748/wjg.v27.i42.7210. World J Gastroenterol. 2021. PMID: 34876784 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources